The influence of three endothelin-1 polymorphisms on progression of IgA nephropathy

Folia Biologica

Volumn 53, Issue 1, 2007, Pages 27-32

  Maixnerová, Dita ^a   Merta, M ^a   Reiterova J ^a   Sterkrova J ^a   Rysava R ^a   Obeidova H ^a   Viklicky O ^b   Potmesil P ^c   Tesar V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Endothelin 1; IgA nephrotherapy; Polymorphism; Renal failure

Indexed keywords

ENDOTHELIN 1;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33847405823     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barratt, J., Feehally, J., Smith, A. C. (2004) Pathogenesis of IgA nephropathy. Semin. Nephrol. 24, 197-217.
2. Bonnet, F., Deprele, C., Sassolas, A., Moulin, P., Alamartine, E., Berthezene, F., Berthoux, F. (2001) Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am. J. Kidney Dis. 37, 720-727.
3. Buck, K. S., Barratt, J., Feehally, J., Smith, A. C. (2003) Beta-1-3-galactosyltransferase activity in IgA nephropathy. J. Am. Soc. Nephrol. 14, 632A.
4. Floege, J., Feehally, J. (2000) IgA nephropathy: Recent developments. J. Am. Soc. Nephrol. 11, 2395-2403.
5. Gharavi, A. G., Yan, Y., Scolari, F. (2000) IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat. Genet. 26, 354-357.
6. Goto, S., Narita, L, Saito, N., Watanabe, Y., Yamazaki, H., Sakatsume, M., Shimada, H., Nishi, S., Ueno, M., Akazawa, K., Arakawa, M., Gejyo, F. (2002) A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int. 62, 980-985.
7. Hiki, Y., Kokubo, T., Iwase, H. (1999) Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J. Am. Soc. Nephrol. 10, 760-769.
8. Jin, J. J., Nakura, J., Wu, Z., Yamamoto, M., Abe, M., Tabara, Y. (2003) Association of endothelin-I gene variant with hypertension. Hypertension 41, 163-167.
9. Johnson, R. J., Kivlighn, S. D., Kim, Y. G., Suga, S., Fogo, A. B. (1999) Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am. J. Kidney Dis. 33, 225-34.
10. Johnson, J. R., Feehally, J. (2003) IgA nephropathy and Henoch-Schonlein nephritis. Clin. Nephrol. 24, 319-329.
11. Kokubo, T., Hiki, Y., Iwase, H. (1999) Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 14, 81-85.
12. Kokubo, T., Hashizumne, K., Iwase, H. (2000) Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 15, 28-33.
13. Lajemi, M., Gautier, S., Poirier, O. (2001) Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives. Am. J. Hypertens. 14, 755-760.
14. Lejny, J. C. K., Poon, P. Y. K., Lai, K. N. (1999) Increased sialylation of polymeric immunoglobulin Al: Mechanism of selective glomerular deposition in inummoglobulin A nephropathy? J. Lab. Clin. Med. 133, 152-160.
15. Magistroni, R., Pei, Y. (2003) IgA nephropathy: A family affair. Nephrology Rounds 4, 1.
16. Mestecky, J., Tomana, M., Crowley-Nowick, P. A., Moldoveanu, Z., Julian, B. A., Jackson, S. (1993) Defective galactosylation and clearance of IgA 1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 104, 172-182.
17. Mestecky, J., Novak, J., Julian, B. A.(2002) Pathogenic potential of galactose-deficient IgA1 in IgA nephropathy. Nephrology 7, S92-S99.
18. Narita, I., Goto, S., Saito, N., Song, J., Omori, K., Kondo, D., Sakatsume, M., Gejyo, F. (2003 a) Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. Kidney Int. 64,1050-1058.
19. Narita, I., Goto, S., Saito, N., Song, J., Ajiro, J., Sato, F., Saga, D., Kondo, D., Akazawa, K., Sakatsume, M., Gejyo, F. (2003 b) Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA ncphropathy in Japanese patients. Hypertension 42, 304-309.
20. Novak, J., Vu, H. L., Novak, L. (2002) Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int. 62, 465-475.
21. Novak, J., Tomana, M., Matousovic, K. (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 67, 504-513.
22. Pinto-Sietsma, S. J., Hermann, S. M., Schmidt-Peterson, K., Niu, T. (2003) Role of the endothelin- I gene locus for renal impairment in the general nondiabetic population. J. Am. Soc. Nephrol. 14, 2596-2602.
23. Schena, F. P., Cerullo, G., Rossini, M., Lanzilotta, S. G., D'Altri, Ch., Manno, C. (2002) Increased risk of end-stage renal disease in familial IgA nephropathy. J. Am. Soc. Nephrol. 13, 453-460.
24. Scolari, F. (2003) Inherited forms of IgA nephropathy. J. Nephrol. 16, 317-320.
25. Song, J., Sakatsume, M., Narita, I., Goto, S., Omori, K., Takada, T., Saito, N., Ueno, M., Gejyo, F. (2003) Peroxisome proliferator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy. Clin. Genet. 64,398-403.
26. Suzuki, H., Suzuki, Y., Yamanaka, T., Hirose, S., Nishimura, H., Toei, J., Horikoshi, S., Tomino, Y (2005) Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J. Am. Soc. Nephrol. 16,1289-1299.
27. Syrjanen, J., Huang, X. H., Mustonen, J., Koivula, T., Lehtimaki, T., Pasternack, A. (2000) Angiotensin-converting enzyme insertion/deletion polymorphism. and prognosis of IgA nephropathy. Nephron 86, 115-121.
28. Syrjanen, J., Mustonen, J., Pasternack, A. (2000) Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol. Dial. Transplant. 15, 34-42.
29. Tahala, C. H., Kamide, K., Takiuchi, S., Kawano, Y., Miyata, T. (2004) Evaluation of the Lysl98Asn and -134de1A genetic polymorphisms of the endothelin-1 gene. Hypertens. Res. 27,367-371.
30. Tiret, L., Poirier, O., Hallet, V, McDonagh, T. A., Morrison, C., McMurray, J. J., Dargie, H. J., Arveiler, D., Ruidavets, J. B., Luc, G., Evans, A., Cambien, F. (1999) The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33, 1169-1174.
31. Tomana, M., Matousovic, K., Julian, B. A. (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52, 509-516.
32. Tomana, M., Novak, J., Julian, B. A. (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73-81.